The workplace services platform raised the money in a JLL Technologies-led round just four months after its series B, and is using the cash to buy competitor Managed by Q.

Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.

The wearable defibrillator developer revealed GV is an existing investor as it raised more than $145m that will support the launch of its lead product.

Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.

The Allianz and Northwestern Mutual-backed life insurance portal received $37.5m in a round led by Brewer Lane Ventures that took its overall funding past $90m.

BlueCross BlueShield Venture Partners co-led a series C round for AxialHealthcare, developer of a medication-addiction mitigation platform.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Baidu, TAL Education and New Oriental-backed children's audio content platform has secured series C-plus funding in a round led by TrustBridge Partners.

LS Corp led a round for the IoT software developer that included subsidiaries of Dell, Intel, Saudi Aramco, Honeywell, General Electric and Robert Bosch.

GV and Intel Capital returned to reinvest in the computing technology provider, which was co-founded by Stanford professors and has now raised more than $450m altogether.